Covered recipient · General Payments record
DEJAN JURIC
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$213,125.50
- Reported across 123 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $20,050.00 | 5 |
| Travel and Lodging | $1,456.47 | 3 |
| Food and Beverage | $144.30 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novartis Pharma AG | $15,648.68 | 5 |
| F. Hoffmann-La Roche AG | $2,850.00 | 2 |
| PFIZER INC. | $2,477.09 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $675.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| F. Hoffmann-La Roche AG | $760.00 | 04/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133000621 | CMS |
| F. Hoffmann-La Roche AG | $2,090.00 | 11/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133000625 | CMS |
| Novartis Pharma AG | $470.95 | 10/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152815265 | CMS |
| Novartis Pharma AG | $532.54 | 10/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152815267 | CMS |
| Novartis Pharma AG | $452.98 | 10/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1152815269 | CMS |
| Novartis Pharma AG | $67.21 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152815281 | CMS |
| Novartis Pharma AG | $14,125.00 | 12/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1152815275 | CMS |
| Novartis Pharmaceuticals Corporation | $675.00 | 10/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1086962790 | CMS |
| PFIZER INC. | $77.09 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132025959 | CMS |
| PFIZER INC. | $2,400.00 | 06/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1131794375 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.